Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia

Gang Chen, Jing Xu, Xiaoyu He, Yixin Yan, Linhui Hu, Zhenjiang Li
Clinical Immunology · Elsevier · DOI: 10.1016/j.clim.2026.110785

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles